Join us at C-Path’s 5th Annual Patient-Reported Outcome (PRO) Consortium Workshop!
Adelphi Values will be participating in the Critical Path Institute’s (C-Path) 5th Annual Patient-Reported Outcome (PRO) Consortium Workshop in Silver Spring, MD on April 29-30, 2014 and would be happy to meet with sponsors who are attending. Alan Shields, Cheryl Coon, Rob Arbuckle, Adam Gater and Nikki Bonner will all be attending to represent the Adelphi Values global team and to support our collaborations with the PRO Consortium and its sponsor members.
Rob Arbuckle, Director of Endpoint Development and Outcomes Assessment at Adelphi Values will be one of the speakers on the panel session: Developing a pediatric COA measurement strategy; a case study in asthma. The objective of this session is to discuss issues in designing endpoints for pediatric asthma drug development programs and should provide a useful case study for other disease areas.
Rob is looking forward to sharing learnings from the numerous pediatric PRO development projects he has worked on and said, “It’s great to be part of the discussion panel and to see pediatric PROs at the center of such a visible event in the field”.
Adelphi Values is the selected COA development vendor for three of the seven active PRO development projects being run by C-Path in the areas of asthma, functional dyspepsia and mild cognitive impairment.
If you will be attending the meeting we’d love to meet with you.
The PRO Consortium is a public-private partnership established by C-Path in cooperation with the U.S. Food and Drug Administration (FDA) and the medical products industry in 2008.